Resistance to β-lactams in enterococci

Rev Argent Microbiol. 2019 Apr-Jun;51(2):179-183. doi: 10.1016/j.ram.2018.01.007. Epub 2018 Sep 20.

Abstract

Enterococci are intrinsically resistant to several antimicrobial classes and show a great ability to acquire new mechanisms of resistance. Resistance to β-lactam antibiotics is a major concern because these drugs either alone or in combination are commonly used for the treatment of enterococcal infections. Ampicillin resistance, which is rare in Enterococcus faecalis, occurs in most of the hospital-associated Enterococcus faecium isolates. High-level resistance to ampicillin in E. faecium is mainly due to the enhanced production of PBP5 and/or by polymorphisms in the beta subunit of this protein. The dissemination of high-level ampicillin resistance can be the result of both clonal spread of strains with mutated pbp5 genes and horizontal gene transfer.

Keywords: Antimicrobial resistance; Enterococci; Enterococcus faecalis; Enterococcus faecium; Enterococos; Resistencia; β-Lactams; β-Lactámicos.

Publication types

  • Review

MeSH terms

  • Drug Resistance, Bacterial
  • Enterococcus / drug effects*
  • Gram-Positive Bacterial Infections / drug therapy
  • Humans
  • Lactobacillales
  • Microbial Sensitivity Tests
  • beta-Lactams / pharmacology*
  • beta-Lactams / therapeutic use

Substances

  • beta-Lactams